We previously showed that GFI1B deficiency is associated with inferior prognosis in MDS/AML patients and significantly increases LSCs number, partially resulting from epigenetic alterations of Gfi1b target genes [15], but additional mechanisms might contribute to this. The gene discussed is GFI1B; the disease is acute myeloid leukemia.